en

PRODUCT DETAIL

Zessly 100 mg prášok na prípravu infúzneho koncentrátu

Code 8173C
MA number EU/1/18/1280/003
Product Form: plc ifc 3x100 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB02 Infliximab
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 18.05.2018
Validity: 18.05.2023
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 21.06.2018
eu-flag.png sk-flag.png